Carboplatin Injection 150mg Manufacturer India

 

Introduction

Cancer treatment today demands not only advanced clinical protocols but also a reliable supply of high-quality oncology drugs. One of the workhorse agents in the platinum-based chemotherapy class is Carboplatin. At Medyra Pharma, we are committed to manufacturing and supplying Carboplatin Injection 150 mg in India and globally — under rigorous quality systems, so that hospitals and patients get consistent, dependable therapy.

What is Carboplatin and Why the 150 mg Strength Matters

Carboplatin is a platinum coordination compound used in chemotherapy, functioning by binding to DNA in rapidly dividing cancer cells and stopping their replication.

In India, the typical presentation often seen is “10 mg/mL” strength, so a 150 mg/15 mL vial corresponds to 10 mg/mL × 15 mL. For example, a manufacturer lists:

“Carboplatin Injection BP 10 mg/mL (50 mg/5 mL, 150 mg/15 mL, 450 mg/45 mL, 600 mg/60 mL)”

The 150 mg strength is widely used in institutional settings for certain oncology regimens (ovarian, lung, head-and-neck), and being able to reliably supply this size is key for oncology centres.

Why Choose Medyra Pharma for Carboplatin 150 mg in India

Here’s why Medyra stands out:

·         Indian manufacturing base, export readiness: India is recognised as a major supplier of Carboplatin (API and finished injection) in the global oncology market. For instance, sources show multiple Indian manufacturers and exporters of Carboplatin Injection at 150 mg strength.

·         Quality compliance: We adhere to WHO-GMP standards, documentation, batch testing, stability studies and regulatory compliance (important for oncology drug reliability).

·         Flexible packaging & supply: The 150 mg/15 mL vial (10 mg/mL) format is compatible with many chemotherapy centres; we also support export packing, cold chain if required, and logistics.

·         Transparent business terms & B2B focus: As a manufacturer serving hospitals, distributors and institutional buyers, we deliver on pricing, timely dispatch, specification clarity and after-sales support.

·         Focused on oncology market: Unlike general pharma players, we specialise in oncology segments — which means our manufacturing, packaging, documentation and supply chain are tuned to the specialised needs of cytotoxic drugs.

Clinical & Technical Highlights for Buyers

Indications
Carboplatin is used in various cancers: advanced ovarian cancer, small-cell lung cancer, head and neck cancer, bladder cancer, testicular cancer and others.
Strength & dosing
For example, the 10 mg/mL formulation is used at 50 mg/5mL, 150 mg/15mL etc.
Packaging / handling
350 mg/15 mL format or 150 mg/15 mL is among standard types. Storage below 25-30 °C in a cool dry place is advised; protect from light.
Side-effect & monitoring notes
Important for institutions: carboplatin may cause myelosuppression (low blood counts), nephrotoxicity, nausea/vomiting, neuropathy. Monitoring of blood counts, kidney/liver function is essential.
Supply-chain/quality notes
When purchasing large-volume for institutions, key criteria include: authenticated manufacturer, GMP compliance, stability data, cold chain assurance (if applicable), full documentation (COA, batch certificate), secure vial sealing, expiry shelf-life. Indian market listings show multiple suppliers for 150 mg/15 mL format.

How Medyra Pharma Supports Institutional Buyers

·         Customised supply contracts: We work with hospital supply chains, government tenders, and private oncology centres — supporting large-volume logistical needs.

·         Documentation support: We provide full batch records, stability certificates, export documentation (if needed), regulatory dossiers for institutional use.

·         On-time & reliable dispatch: We understand the criticality of oncology drug supply disruption — our supply chain is geared for timely dispatch, secure vials, proper packing.

·         Technical liaison: For pharmacists, oncologists or procurement teams, we can provide product specification sheets, storage guidelines, handling instructions, safety data sheets.

·         Post-sale support: Visible expiry tracking, stock rotation advice, recalls (if ever necessary) or alerts on regulatory changes.

Why Indian Manufacture Matters

India’s role as an oncology drug manufacturing hub means competitive pricing with global standards. As per a directory, Indian manufacturers of Carboplatin Injection (150 mg, 450 mg) ensure availability, local regulatory approvals, and cost-efficiencies. For an institutional buyer, sourcing from a trusted Indian manufacturer like Medyra Pharma means: more direct supply, lower lead-time, reliable regulatory track, and cost-effective sourcing.

Key Take-aways for Procurement Teams

·         Confirm the strength you need (for example, 150 mg/15 mL vial) and match with your dosing regimen.

·         Always check manufacturer credentials: GMP certificate, oncology manufacturing licence, COA for each batch.

·         Check packaging, storage conditions, supply timelines.

·         Factor in after-sales support (documentation, batch traceability).

·         With Medyra Pharma, you get a partner who specialises in oncology supply, not just general pharmaceuticals.

Conclusion

For hospitals, oncology centres and distributors seeking Carboplatin Injection 150 mg from a reliable Indian manufacturer, Medyra Pharma offers a robust solution — combining quality, supply reliability and institutional-grade service. When every dose matters in cancer care, your supplier must be one you can trust.